ficusin has been researched along with clofazimine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandy, KG; Gulbins, E; Henry, B; Leanza, L; Sassi, N; Szabò, I; Zoratti, M | 1 |
| Becker, KA; Frezzato, F; Gulbins, E; Leanza, L; Semenzato, G; Szabo, I; Trentin, L; Zoratti, M | 1 |
2 other study(ies) available for ficusin and clofazimine
| Article | Year |
|---|---|
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cells, Cultured; Clofazimine; Down-Regulation; Ficusin; Humans; Jurkat Cells; Kv1.3 Potassium Channel; Melanoma, Experimental; Mice; Mitochondria; Pancreatitis-Associated Proteins; Potassium Channel Blockers; RNA Interference; RNA, Small Interfering; Signal Transduction | 2012 |
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.
Topics: Clofazimine; Ficusin; Humans; Kv1.3 Potassium Channel; Leukemia, Lymphocytic, Chronic, B-Cell; Pancreatitis-Associated Proteins; Potassium Channel Blockers | 2013 |